E-Learning

Broadcom, Arista Networks initiated: Wall Street's top analyst calls

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Based on the average brokerage recommendation (ABR), Exxon (XOM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Based on the average brokerage recommendation (ABR), Blue Bird (BLBD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

According to the average brokerage recommendation (ABR), one should invest in Coupang (CPNG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

According to the average brokerage recommendation (ABR), one should invest in Broadwind Energy (BWEN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

The average brokerage recommendation (ABR) for New Gold (NGD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.